This year's AdvaMed MedTech Conference in Boston was a fantastic event. OBIO was in attendance for meetings and conversations with US and global investors and strategics about what's coming up for the health science industry in Canada. There was tons of enthusiasm and interest to capitalize on as we head into 2020.
Recap: OBIO CAAP Alumni Group Dinner
Reviewing OBIO at RESI Boston
On September 10th, OBIO organized a cross-border networking event in Boston at the Consulate General of Canada. The event was supported by the Consulate General and law firms Fasken and Choate. Over 45 investors, strategics, as well as executives from high potential Canadian health science companies packed the Canada Room at the Consulate and resulted in numerous investor-company interactions.
FedDev Ontario announces $6.24 million investment in OBIO
FedDev Ontario is investing up to $6.24 million for the Ontario Bioscience Innovation Organization (OBIO®) to boost investment, market access and mentorship opportunities for companies across southern Ontario looking to commercialize their medical innovations.
Reviewing 'In-Licensing from Tech Transfer Offices: Terms, Tips & Impact on Investability'
On August 21st, OBIO hosted Norton Rose Fulbright’s Anthony de Fazekas (Partner, Head of Technology & Innovation) and Vanessa Grant (Partner), Lumira Ventures’ Jacki Jenuth (Partner), and University of Toronto’s Karen Temple (Commercialization Manager) who discussed practical considerations for licensing health science technologies from tech transfer offices, and how these agreements can impact a company’s future investability.
OBIO Hosts Happy Hour Networking Event
OBIO Announces National Call to Canadian Health Science Companies for Applications for the 2020 Niagara Investment Summit
Recapping 'Optimize Your Next Round of Funding'
Reviewing 'Is the Price Right? Pricing Your Innovative Healthcare Product'
Send OBIO Your Red Tape Reduction Ideas
If your company has experience with an unnecessary, duplicative or frustrating hurdle in the course of doing business, OBIO wants to know. Please tell us what the challenges are and how they impact your company. As part of OBIO’s engagement with the provincial government, the health science industry’s recommendations on red tape or regulatory burdens that can be addressed are being sought by the Government of Ontario.
Recapping Pitches & Pitchers
Why Ontario needs a network of Early Adopter Health Organizations: Biotechnology Focus
In the latest issue of Biotechnology Focus, OBIO President and CEO Gail Garland contributed a special report: Why Ontario needs a network of Early Adopter Health Organizations
Recapping 2019 OBIO Queen's Park Health Science Industry Showcase
Apply to Pitch and Get Feedback from the Mid Atlantic Bio Angels, May 23
Apply to be one of 4 OBIO member companies to pitch to the Mid Atlantic Bio Angels (MABA), a group of active angel investors based in New York City. Companies will receive constructive feedback on what they need to have in place prior to applying for investment from MABA or similar groups to improve their chances of getting investment.
Achieving Impact Through Adoption of Innovative Health Technologies: Establishing Early Adopter Health Organizations as an Accelerator for Economic Growth in Ontario
The Ontario Bioscience Innovation Organization (OBIO®) today released its latest report, ‘Achieving Impact Through Adoption of Innovative Health Technologies: Establishing Early Adopter Health Organizations as an Accelerator for Economic Growth in Ontario’, which describes an early adopter model to facilitate the evaluation and adoption of innovative health technologies in Ontario health organizations.
OBIO Announces Launch of OBIO CAAP® for 2019
The Ontario Bioscience Innovation Organization (OBIO®) is proud to announce its 2019 Capital Access Advisory Program (CAAP®) and the high-potential health science companies in this year’s program.
Federal Budget 2019 Analysis
OBIO Announces Successful 2019 Niagara Investment Summit
OBIO® (Ontario Bioscience Innovation Organization) is proud to announce the success of the 2019 Niagara Investment Summit on February 20-22, 2019. The 2019 Niagara Investment Summit featured over 30 of Canada’s most promising innovative health science companies and more than 30 US and global investors and VCs.
OBIO Opens 2019 Niagara Investment Summit, Connecting Canada’s Most Promising Innovations with Leading Global Investors
OBIO is proud to announce the opening of the 2019 Niagara Investment Summit in Niagara-on-the-Lake, Ontario, on February 21-22, 2019. The 2019 Niagara Investment Summit will feature over 30 of Canada’s most promising innovative health science companies meeting with more than 30 US and global investors and VCs in Niagara-on-the-Lake to propel investment in Canada’s health science industry.